Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples
- 1 April 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 93 (1) , 98-106
- https://doi.org/10.1016/j.ygyno.2003.11.053
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Biomarker Conservation in Primary and Metastatic Epithelial Ovarian CancerGynecologic Oncology, 2000
- Immunophenotype of Ovarian Cancer as Predictor of Clinical Outcome: Evaluation at Primary Surgery and Second-Look ProcedureGynecologic Oncology, 1998
- Detection of P‐glycoprotein in frozen and paraffin‐embedded gastric adenocarcinoma tissues using a panel of monoclonal antibodiesHistopathology, 1998
- Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven PolymerizationJournal of Biological Chemistry, 1997
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Altered Expression of Mβ2, the Class II β-Tubulin Isotype, in a Murine J774.2 Cell Line with a High Level of Taxol ResistanceJournal of Biological Chemistry, 1995
- The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian CancerNew England Journal of Medicine, 1995
- Clinical Correlates of MDR1 (P-glycoprotein) Gene Expression in Ovarian and Small-Cell Lung CarcinomasJNCI Journal of the National Cancer Institute, 1992
- Interactions between antitumour agents and radiation and the expression of resistanceCancer Treatment Reviews, 1991